BamSEC and AlphaSense Join Forces
Learn More

Eledon Pharmaceuticals Inc. – Transcripts

NASDAQ: ELDN    
Share price (3/24/26): $2.89    
Market cap (3/24/26): $219 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2025
Other Revised 11/17/25 Eledon Pharmaceuticals, Inc. Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference, Nov-12-2025 10:30 AM 11/12/25 Other Revised 12/09/25 Eledon Pharmaceuticals, Inc. - Special Call 11/07/25 Other Revised 08/07/25 Eledon Pharmaceuticals, Inc. - Special Call 08/06/25 Other Revised 07/09/25 Eledon Pharmaceuticals, Inc. - Special Call 07/09/25
CY 2023
Other Revised 11/06/23 Eledon Pharmaceuticals, Inc. - Special Call 11/02/23 Earnings Revised 07/04/24 Eledon Pharmaceuticals, Inc., Q1 2023 Earnings Call, May 11, 2023 05/11/23 Earnings Revised 03/30/23 Eledon Pharmaceuticals, Inc., Q4 2022 Earnings Call, Mar 30, 2023 03/30/23
CY 2022
Earnings Revised 11/14/22 Eledon Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 14, 2022 11/14/22 Earnings Revised 08/11/22 Eledon Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 11, 2022 08/11/22 Other Revised 05/31/22 Eledon Pharmaceuticals, Inc. - Special Call 05/31/22 Earnings Revised 05/12/22 Eledon Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022 05/12/22 Other Revised 04/28/22 Eledon Pharmaceuticals, Inc. - Special Call 04/28/22 Earnings Revised 03/24/22 Eledon Pharmaceuticals, Inc., Q4 2021 Earnings Call, Mar 24, 2022 03/24/22
CY 2021
Earnings Revised 11/11/21 Eledon Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 11, 2021 11/11/21 Earnings Revised 08/12/21 Eledon Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 12, 2021 08/12/21 Earnings Revised 05/13/21 Eledon Pharmaceuticals, Inc., Q1 2021 Earnings Call, May 13, 2021 05/13/21 Earnings Revised 08/01/25 Eledon Pharmaceuticals, Inc., Q4 2020 Earnings Call, Mar 30, 2021 03/30/21
CY 2020
Earnings Revised 11/16/20 Novus Therapeutics, Inc., Q3 2020 Earnings Call, Nov 16, 2020 11/16/20 Other Revised 09/15/20 Anelixis Therapeutics, LLC, Novus Therapeutics, Inc. - M&A Call 09/15/20